台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣諾華股份有限公司 台北市中山區民生東路三段2號8樓 (01516589) - imatinib mesylate - 膠囊劑 - imatinib mesylate (1013000710) mg - imatinib - 治療正值急性轉化期(blast crisis)、加速期或經alpha-干擾素治療無效之慢性期的慢性骨髓性白血病(cml)患者，治療成年人無法手術切除或轉移的惡性胃腸道基質瘤。用於治療初診斷為慢性骨髓性白血病(cml)的病人。治療初診斷為費城染色體陽性急性淋巴性白血病（ph+ all)且併用化療之成年及兒童患者。做為治療成人復發性或難治性費城染色體陽性急性淋巴性白血病(ph+ all)之單一療法。治療患有與血小板衍生生長因子受體（pdgfr)基因重組相關之骨髓發育不全症候群(mds)/骨髓增生性疾病(mpd)之成人患者。治療患有系統性肥大細胞增生症(sm)，限具fip1l1-pdgfr基因變異且不具有c-kit基因d816v突變之成人患者。治療嗜伊紅性白血球增加症候群(hes)與或慢性嗜伊紅性白血病(cel)且有血小板衍生生長因子受體(pdgfr)基因重組之成人患者。作為成人kit(cd 117)陽性胃腸道基質瘤完全切除(complete gross resection)後之術後輔助治療。治療患有無法手術切除、復發性或轉移性且有血小板衍生生長因子受體(pdgfr)基因重組之隆突性皮膚纖維肉瘤(dfsp)之成人患者。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

美商默沙東藥廠股份有限公司台灣分公司 台北市信義區信義路五段106號12樓 (86683720) - etonogestrel - 植入劑 - etonogestrel (6832003000) mg - etonogestrel - 避孕。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

政德製藥股份有限公司 雲林縣大埤鄉嘉興村豐田路２號 (63129193) - methylprednisolone (sodium succinate) - 乾粉注射劑 - methylprednisolone (sodium succinate) (6804091331) mg - methylprednisolone - 腎上腺皮質機能不全、劇烈休克、支氣管性氣喘、膠原疾病、過敏反應、泛發性感染。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣邁蘭有限公司 臺北市信義區信義路５段7號27樓 (25122352) - pramipexole ( pramipexole dihydrochloride monohydrate) - 錠劑 - pramipexole ( pramipexole dihydrochloride monohydrate) (7600001520) (equivalent to pramipexole 0.18mg)mg - pramipexole - 治療自發性巴金森氏症的徵候及症狀、治療原發性腿部躁動症(primary restless legs syndrome)的症狀。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

傑特貝林有限公司 臺北市信義區基隆路1段333號16樓(1612室) (43836487) - immunoglobulin human - 注射液劑 - immunoglobulin human (8004000603) human plasma protein with at least 98% iggmg - immunoglobulins, normal human, for intravascular adm. - 作為替代療法：1.原發性免疫不全症(primary immunodeficiency syndromes，pid)如：(1)先天性丙種免疫球蛋白缺乏症(congenital agammaglobulinemia)及丙種免疫球蛋白過低症(hypogammaglobulinemia)(2)常見變異性免疫不全症(common variable immunodeficiency)(3)嚴重複合型免疫不全症(severe combined immunodeficiency)(4)wiskott- aldrich氏症候群2.慢性淋巴性白血病引致丙種免疫球蛋白過低與復發性細菌感染，且預防性抗生素治療無效的病人。3.多發性骨髓瘤穩定期(plateau phase)引致丙種免疫球蛋白過低與復發性細菌感染，且施打肺炎鏈球菌疫苗無效的病人。4.異體造血幹細胞移植後引致丙種免疫球蛋白過低。5.先天性愛滋病(aids)伴隨復發性細菌感染者。作為免疫調節：1.免疫性血小板缺乏紫斑症(immune thrombocytopenic purpura, itp)，且具高出血風險或用於手術前矯正血小板計數。2.格林-巴利症候群(guillain-barré syndrome)。3.川崎氏症(kawasaki disease) （與乙醯水楊酸acetylsalicylic acid一起使用；請參閱“劑量/用法”章節。）。4.慢性脫髓鞘多發性神經炎(chronic inflammatory demyelinating polyneuropathy, cidp)，對孩童的使用經驗有限。5.多灶性運動神經病變 (multifocal motor neuropathy, mmn)。6.重症肌無力惡化(myasthenia gravis exacerbations, mg)。7.藍伯-伊頓肌無力症(lambert-eaton myasthenic syndrome)。8.僵體徵候群(stiff person syndrome)。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

景德製藥股份有限公司 台北市中山區中山北路二段113號8樓 (03436008) - cilostazol - 錠劑 - cilostazol (2408005500) mg - platelet aggregation inhibitors excl. heparin - 使用於無休息時疼痛及周邊組織壞死之間歇性跛行病人(周邊動脈疾病fontaine stage ii)，用於增加最大及無痛行走距離及經生活模式改變(包含戒菸及運動計畫)及其他治療後，仍無法充分改善間歇性跛行症狀病人之二線治療。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - methionine;;phenylalanine;;threonine;;tryptophan;;arginine monoglutamate l-;;histidine hcl monohydrate;;alanine;;aspartic acid;;glutamic acid;;proline;;serine;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;potassium hydroxide;;sodium hydroxide;;glucose (monohydrate);;sodium chloride;;calcium chloride dihydrate;;leucine;;lysine hcl;;glycine (eq to aminoacetic acid)(eq to glycocoll);;magnesium acetate tetrahydrate;;valine;;isoleucine;;potassium dihydrogen phosphate - 注射劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) 1.56gm; calcium chloride dihydrate (4012000350) 0.37gm; magnesium acetate tetrahydrate (4012001450) 0.86gm; sodium chloride (4012002100) 0.17gm; glucose (monohydrate) (4020009760) 88.00gm; alanine (4020100200) 4.85gm; arginine monoglutamate l- (4020100342) 4.98gm; aspartic acid (4020100400) 1.50gm; glutamic acid (4020100700) 1.22gm; histidine hcl monohydrate (4020100915) 1.69gm; isoleucine (4020101000) 2.34gm; leucine (4020101200) 3.13gm; lysine hcl (4020101310) 2.84gm; methionine (4020101500) 1.96gm; phenylalanine (4020101700) 3.51gm; proline (4020101800) 3.40gm; serine (4020101900) 3.00gm; threonine (4020102000) 1.82gm; tryptophan (4020102100) 0.57gm; valine (4020102300) 2.60gm; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 1.65gm; potassium dihydrogen phosphate (5612001920) 0.78gm; potassium hydroxide (9600024100) gm; sodium hydroxide (9600028200) 0.50gm - combinations - 無法經口服攝食或腸道吸收營養、功能不全或有禁忌症時，對輕微到中等異化作用狀態的病人的靜脈營養提供氨基酸、葡萄糖、電解質和液體。欣保康力靜脈營養輸注液適用於成人和2 到17 歲的兒童。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - isoleucine;;leucine;;lysine hcl;;methionine;;threonine;;valine;;arginine;;histidine hcl monohydrate;;alanine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;aspartic acid;;glutamic acid;;proline;;serine;;phenylalanine;;tryptophan;;glucose monohydrate;;sodium hydroxide;;sodium chloride;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;sodium dihydrogen phosphate dihydrate;;potassium acetate;;magnesium acetate tetrahydrate;;calcium chloride dihydrate;;zinc acetate dihydrate;;triglycerides medium chain;;soybean oil ( eq to soya bean oil) - 注射劑 - potassium acetate (4008000100) mg; sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; calcium chloride dihydrate (4012000350) mg; magnesium acetate tetrahydrate (4012001450) mg; sodium chloride (4012002100) mg; glucose monohydrate (4020000760) (eq. to anhydrous glucose 64.0mg)mg; soybean oil ( eq to soya bean oil) (4020001600) mg; alanine (4020100200) mg; arginine (4020100300) mg; aspartic acid (4020100400) mg; glutamic acid (4020100700) mg; histidine hcl monohydrate (4020100915) (eq. to histidine 1.0 mg)mg; isoleucine (4020101000) mg; leucine (4020101200) mg; lysine hcl (4020101310) (eq. to lysine 1.81mg)mg; methionine (4020101500) mg; phenylalanine (4020101700) mg; proline (4020101800) mg; serine (4020101900) mg; threonine (4020102000) mg; tryptophan (4020102100) mg; valine (4020102300) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; sodium dihydrogen phosphate dihydrate (5612002611) mg; triglycerides medium chain (5640001102) mg; zinc acetate dihydrate (9200010550) ug; sodium hydroxide (9600028200) mg - combinations - 患者在無法使用或不適宜或不充足使用口服，腸道營養劑時，作為靜脈營養治療之熱量、必需脂肪酸、胺基酸、電解質及液體的補充。